Usefulness of Atherectomy in Chronic Total Occlusion Interventions (from the PROGRESS-CTO Registry).


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
01 05 2019
Historique:
received: 12 09 2018
revised: 17 01 2019
accepted: 22 01 2019
pubmed: 26 2 2019
medline: 21 1 2020
entrez: 26 2 2019
Statut: ppublish

Résumé

There is limited data on the use of atherectomy during chronic total occlusion (CTO) percutaneous coronary intervention (PCI). We compared the clinical and procedural characteristics and outcomes of CTO PCIs performed with or without atherectomy in a contemporary multicenter CTO PCI registry. Between 2012 and 2018, 3,607 CTO PCIs were performed at 21 participating centers. Atherectomy was used in 117 (3.2%) cases: rotational atherectomy in 105 cases, orbital atherectomy in 8, and both in 4 cases. Patients in whom atherectomy was used, were older (68 ± 8 vs 64 ± 10 years, p <0.0001) and had higher Japan-chronic total occlusion score (3.0 ± 1.2 vs 2.4 ± 1.3, p <0.0001). CTO PCI cases in which atherectomy was used had similar technical (91% vs 87%, p = 0.240) and procedural (90% vs 85%, p = 0.159) success and in-hospital major adverse cardiac event (4% vs 3%, p = 0.382) rates. However, atherectomy cases were associated with higher rates of donor vessel injury (4% vs 1%, p = 0.031), tamponade requiring pericardiocentesis (2.6% vs 0.4%, p = 0.012) and more often required use of a left ventricular assist device (9% vs 5%, p = 0.031). Atherectomy cases were associated with longer procedural duration (196 [141, 247] vs 119 [76, 180] minutes, p <0.0001), and higher patient air kerma radiation dose (3.6 [2.5, 5.6] vs 2.8 [1.6, 4.7] Gray, p = 0.001). In conclusion, atherectomy is currently performed in approximately 3% of CTO PCI cases and is associated with similar technical and procedural success and overall major adverse cardiac event rates, but higher risk for donor vessel injury and tamponade.

Identifiants

pubmed: 30798947
pii: S0002-9149(19)30186-9
doi: 10.1016/j.amjcard.2019.01.054
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1422-1428

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Iosif Xenogiannis (I)

Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota.

Dimitri Karmpaliotis (D)

Columbia University, New York, New York.

Khaldoon Alaswad (K)

Henry Ford Hospital, Detroit, Michigan.

Farouc A Jaffer (FA)

Massachusetts General Hospital, Boston, Massachusetts.

Robert W Yeh (RW)

Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Mitul Patel (M)

VA San Diego Healthcare System and University of California San Diego, La Jolla, California.

Ehtisham Mahmud (E)

VA San Diego Healthcare System and University of California San Diego, La Jolla, California.

James W Choi (JW)

Baylor Heart and Vascular Hospital, Dallas, Texas.

M Nicholas Burke (MN)

Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota.

Anthony H Doing (AH)

Medical Center of the Rockies, Loveland, Colorado.

Phil Dattilo (P)

Medical Center of the Rockies, Loveland, Colorado.

Catalin Toma (C)

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

A J Conrad Smith (AJC)

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Barry Uretsky (B)

VA Central Arkansas Healthcare System, Little Rock, Arkansas.

Oleg Krestyaninov (O)

Meshalkin Novosibrisk Research Institute, Novosibirsk, Russia.

Dmitrii Khelimskii (D)

Meshalkin Novosibrisk Research Institute, Novosibirsk, Russia.

Elizabeth Holper (E)

The Heart Hospital Baylor Plano, Plano, Texas.

Srinivas Potluri (S)

The Heart Hospital Baylor Plano, Plano, Texas.

R Michael Wyman (RM)

Torrance Memorial Medical Center, Torrance, California.

David E Kandzari (DE)

Piedmont Heart Institute, Atlanta, Georgia.

Santiago Garcia (S)

VA Minneapolis Healthcare System and University of Minnesota, Minneapolis, Minnesota.

Michalis Koutouzis (M)

Red Cross Hospital of Athens, Athens, Greece.

Ioannis Tsiafoutis (I)

Red Cross Hospital of Athens, Athens, Greece.

Jaikirshan J Khatri (JJ)

Cleveland Clinic, Cleveland, Ohio.

Wissam Jaber (W)

Emory University Hospital Midtown, Atlanta, Georgia.

Habib Samady (H)

Emory University Hospital Midtown, Atlanta, Georgia.

Brian K Jefferson (BK)

Tristar Centennial Medical Center, Nashville, Tennesse.

Taral Patel (T)

Tristar Centennial Medical Center, Nashville, Tennesse.

Jeffrey W Moses (JW)

Columbia University, New York, New York.

Nicholas J Lembo (NJ)

Columbia University, New York, New York.

Manish Parikh (M)

Columbia University, New York, New York.

Ajay J Kirtane (AJ)

Columbia University, New York, New York.

Ziad A Ali (ZA)

Columbia University, New York, New York.

Darshan Doshi (D)

Columbia University, New York, New York.

Peter Tajti (P)

Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota; Division of Invasive Cardiology, Second Department of Internal Medicine and Cardiology Center, University of Szeged, Szeged, Hungary.

Bavana V Rangan (BV)

Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota.

Shuaib Abdullah (S)

VA North Texas Health Care System and University of Texas Southwestern Medical Center, Dallas, Texas.

Subhash Banerjee (S)

VA North Texas Health Care System and University of Texas Southwestern Medical Center, Dallas, Texas.

Emmanouil S Brilakis (ES)

Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota. Electronic address: esbrilakis@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH